These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9556609)

  • 1. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor.
    Fuh G; Li B; Crowley C; Cunningham B; Wells JA
    J Biol Chem; 1998 May; 273(18):11197-204. PubMed ID: 9556609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
    Tao Q; Backer MV; Backer JM; Terman BI
    J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study.
    Cunningham SA; Tran TM; Arrate MP; Brock TA
    J Biol Chem; 1999 Jun; 274(26):18421-7. PubMed ID: 10373449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies.
    Lu D; Kussie P; Pytowski B; Persaud K; Bohlen P; Witte L; Zhu Z
    J Biol Chem; 2000 May; 275(19):14321-30. PubMed ID: 10799512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
    Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
    Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA; Christinger HW; Keyt BA; de Vos AM
    Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor.
    Shinkai A; Ito M; Anazawa H; Yamaguchi S; Shitara K; Shibuya M
    J Biol Chem; 1998 Nov; 273(47):31283-8. PubMed ID: 9813036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.
    Roeckl W; Hecht D; Sztajer H; Waltenberger J; Yayon A; Weich HA
    Exp Cell Res; 1998 May; 241(1):161-70. PubMed ID: 9633524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
    Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
    Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
    Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
    Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
    Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
    Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
    J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV; Brace RA; Cheung CY
    Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
    Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
    Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.